Last reviewed · How we verify
Carraghenates Cream
Carraghenates Cream is a Small molecule drug developed by Xian-Janssen Pharmaceutical Ltd.. It is currently FDA-approved.
Carraghenates Cream is a treatment for hemorrhoids, as indicated by a clinical trial on ClinicalTrials.gov. The exact mechanism of action of Carraghenates Cream is unknown, according to ChEMBL.
At a glance
| Generic name | Carraghenates Cream |
|---|---|
| Sponsor | Xian-Janssen Pharmaceutical Ltd. |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Carraghenates Cream CI brief — competitive landscape report
- Carraghenates Cream updates RSS · CI watch RSS
- Xian-Janssen Pharmaceutical Ltd. portfolio CI
Frequently asked questions about Carraghenates Cream
What is Carraghenates Cream?
Who makes Carraghenates Cream?
What development phase is Carraghenates Cream in?
Related
- Manufacturer: Xian-Janssen Pharmaceutical Ltd. — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing